Adocia is managed by a Committee composed of three members: Valérie Danaguezian, CFO, Olivier Soula, VP, R&D Director and Gérard Soula, CEO.

The management of Adocia cumulates more than 65 years of experience in the management of innovation in the pharmaceutical industry.